Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionBeutel, Goodman & Co Ltd.
Latest Disclosed Ownership649,319 shares
Latest Disclosed Value $ 228,462
Beutel, Goodman & Co Ltd. reports 45.09% decrease in ownership of AMGN / Amgen Inc.

On May 15, 2026 - Beutel, Goodman & Co Ltd. filed a 13F-HR form disclosing ownership of 649,319 shares of Amgen Inc. (MX:AMGN) valued at $228,462 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,182,453 shares of Amgen Inc.. This represents a change in shares of -45.09% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Amgen Common 031162100 649,319 -533,134 -45.09 228 -41.09 1.5487
2026-02-13 2025-12-31 13F Amgen Common 031162100 1,182,453 -264,477 -18.28 387 -5.15 2.3776
2025-11-14 2025-09-30 13F Amgen Common 031162100 1,446,930 10,308 0.72 408 1.75 2.4592
2025-08-13 2025-06-30 13F Amgen Common 031162100 1,436,622 37,343 2.67 401 -7.82 2.2855
2025-05-14 2025-03-31 13F/A-1 Amgen Common 031162100 1,399,279 126,854 9.97 436 31.42 2.5123
2025-05-12 2025-03-31 13F Amgen Common 031162100 1,399,279 126,854 436 2.4996
2025-02-12 2024-12-31 13F Amgen Common 031162100 1,272,425 172,542 15.69 332 -6.50 1.8042
2024-11-13 2024-09-30 13F Amgen Common 031162100 1,099,883 -573,408 -34.27 354 -32.18 1.7465
2024-08-13 2024-06-30 13F Amgen Common 031162100 1,673,291 82,036 5.16 523 15.49 2.7786
2024-05-14 2024-03-31 13F/A-1 Amgen Common 031162100 1,591,255 21,598 1.38 452 0.00 2.3307
2024-05-13 2024-03-31 13F Amgen Common 031162100 1,569,657 0 452 2.4099
2024-02-09 2023-12-31 13F Amgen Common 031162100 1,569,657 -5,985 -0.38 452 6.86 2.3978
2023-11-13 2023-09-30 13F Amgen Common 031162100 1,575,642 -300 -0.02 423 21.20 2.5020
2023-08-14 2023-06-30 13F Amgen Common 031162100 1,575,942 204,486 14.91 350 5.44 1.9613
2023-05-12 2023-03-31 13F Amgen Common 031162100 1,371,456 28,165 2.10 332 -5.97 1.9489
2023-02-14 2022-12-31 13F Amgen Common 031162100 1,343,291 -197,888 -12.84 353 -99.90 2.1360
2022-11-14 2022-09-30 13F Amgen Common 031162100 1,541,179 -128,762 -7.71 347,381 -14.50 2.3490
2022-08-15 2022-06-30 13F Amgen Common 031162100 1,669,941 48,505 2.99 406,296 3.62 2.5243
2022-05-12 2022-03-31 13F Amgen Common 031162100 1,621,436 46,105 2.93 392,095 10.64 2.2185
2022-02-14 2021-12-31 13F Amgen Common 031162100 1,575,331 97,584 6.60 354,402 12.78 2.0227
2021-11-12 2021-09-30 13F Amgen Common 031162100 1,477,747 119,022 8.76 314,242 -5.12 1.9235
2021-08-13 2021-06-30 13F Amgen Common 031162100 1,358,725 147,292 12.16 331,189 9.88 1.9694
2021-05-14 2021-03-31 13F Amgen Common 031162100 1,211,433 182,472 17.73 301,416 27.41 1.8923
2021-02-05 2020-12-31 13F Amgen Common 031162100 1,028,961 412,976 67.04 236,578 51.11 1.6020
2020-11-13 2020-09-30 13F Amgen Common 031162100 615,985 -243,516 -28.33 156,558 -22.77 1.2591
2020-08-14 2020-06-30 13F Amgen Common 031162100 859,501 -109,996 -11.35 202,721 3.14 1.6660
2020-05-14 2020-03-31 13F Amgen Common 031162100 969,497 -82,117 -7.81 196,546 -22.47 1.8334
2020-02-24 2019-12-31 13F/A-1 Amgen Common 031162100 1,051,614 -4,770 -0.45 253,512 64.28 1.4548
2020-02-14 2019-12-31 13F Amgen Common 031162100 1,192,598 136,214 287,499 1,498,446.0149
2019-12-23 2019-09-30 13F/A-1 AMGEN COMMON 031162100 1,056,384 -44,127 -4.01 154,317 -0.35 1.0754
2019-10-31 2019-09-30 13F AMGEN COMMON 031162100 1,056,384 -44,127 17,739 1,646,731.1843
2019-08-15 2019-06-30 13F/A-1 AMGEN COMMON 031162100 1,100,511 369,142 50.47 154,859 48.94 1.1218
2019-08-15 2019-06-30 13F AMGEN COMMON 031162100 1,100,511 369,142 154,859
2019-04-30 2019-03-31 13F/A-1 AMGEN COMMON 031162100 731,369 65,821 9.89 103,973 9.52 0.7806
2019-04-26 2019-03-31 13F AMGEN COMMON 031162100 731,369 65,821 103,973
2019-02-11 2018-12-31 13F/A-1 AMGEN COMMON 031162100 665,548 56,365 9.25 94,931 -2.82 0.8082
2019-02-07 2018-12-31 13F AMGEN COMMON 031162100 665,548 56,365 9,493
2018-10-31 2018-09-30 13F AMGEN COMMON 031162100 609,183 -8,347 -1.35 97,688 12.64 0.7060
2018-07-30 2018-06-30 13F/A-1 AMGEN COMMON 031162100 617,530 617,530 86,723 0.6385
2018-07-30 2018-06-30 13F AMGEN COMMON 031162100 617,530 86,723 0.6518
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.